ID: ALA359770

Max Phase: Preclinical

Molecular Formula: C33H30N2O7S

Molecular Weight: 598.68

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)[C@H](NS(=O)(=O)c1ccc(-c2ccc(NC(=O)c3cc4c(OCc5ccccc5)cccc4o3)cc2)cc1)C(=O)O

Standard InChI:  InChI=1S/C33H30N2O7S/c1-21(2)31(33(37)38)35-43(39,40)26-17-13-24(14-18-26)23-11-15-25(16-12-23)34-32(36)30-19-27-28(9-6-10-29(27)42-30)41-20-22-7-4-3-5-8-22/h3-19,21,31,35H,20H2,1-2H3,(H,34,36)(H,37,38)/t31-/m0/s1

Standard InChI Key:  NVNDKOXSOGFACQ-HKBQPEDESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 598.68

Molecular Weight (Monoisotopic): 598.1774

AlogP: 6.32

#Rotatable Bonds: 11

Polar Surface Area: 134.94

Molecular Species: ACID

HBA: 6

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 3.33

CX Basic pKa:

CX LogP: 6.12

CX LogD: 2.70

Aromatic Rings: 5

Heavy Atoms: 43

QED Weighted: 0.16

Np Likeness Score: -0.89

References

1. Wu J, Rush TS, Hotchandani R, Du X, Geck M, Collins E, Xu ZB, Skotnicki J, Levin JI, Lovering FE..  (2005)  Identification of potent and selective MMP-13 inhibitors.,  15  (18): [PMID:16005220] [10.1016/j.bmcl.2005.06.019]

Source

Source(1):

• Scientific Literature